Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2023, Vol. 28 ›› Issue (3): 290-298.doi: 10.12092/j.issn.1009-2501.2023.03.007

Previous Articles     Next Articles

Comparison of common parameter estimation methods in NONMEM 7.5.1.: A case study of ibuprofen injection in Chinese healthy adult population 

LUO Mingjie1, LIU Runhan2,3, ZHOU Jie1, WANG Zhenlei2,3    

  1. 1 College of Mathematics, Sichuan University, Chengdu 610064, Sichuan, China; 2 Department of Clinical Medicine (Department of Pharmacy), West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China; 3 Clinical Trial Center of West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China 
  • Received:2022-10-28 Revised:2022-12-14 Online:2023-03-26 Published:2023-04-19

Abstract:

NONMEM. is a software widely used in the field of population pharmacokinetics and pharmacodynamics, mainly for related data analy-sis. In theory, it mainly establishes a parameterized model, combines the obtained data, and uses dif-ferent parameter estimation methods to estimate the parameters in the model, and then analyzes the data according to the model. This paper briefly introduces the representation of parameterized models in NONMEM., and from statistical theory, summarizes three commonly used parameter esti-mation methods under the condition that the ran-domization effect parameters η and .do not inter-act. For nonlinear mixed effects models, the rela-tionships among three parameter estimation meth-ods are given under special cases of addictive intra-individual models and proportional intra-individual models. In addition, through numerical experi-ments on data of four pharmaceutical companies on the change of ibuprofen drug concentration with time, the rationality of theory is further veri-fied in terms of calculation time and model predic-tion residuals. 

Key words: NONMEM., nonlinear mixed effects model, parameter estimation 

CLC Number: